What is the fiber paradox on GLP-1 drugs
& Moussa, S
Rybelsus : US prescribing information 2020
Patients should also report any symptoms of pancreatitis (severe abdominal pain, sometimes radiating to the back, with or without vomiting), gallbladder problems, or changes in vision, as these may require prompt medical attention and reassessment of treatment
This signals a shift in thinking unlike anything weve seen in a generation a move toward treating obesity first, rather than waiting for people to develop the many complications that follow, Arrone said
The program, which went into effect on July 1, 2026, is available nationwide across all states and territories, marking the first time millions of older adults living with obesity have had a structured pathway to the FDA-approved weight management medicine